{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:02:30Z","timestamp":1759017750062,"version":"3.44.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002886","name":"Foundation for Ichthyosis and Related Skin Types","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002954","name":"Universit\u00e0 degli Studi di Milano-Bicocca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002954","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.leukres.2007.09.008","type":"journal-article","created":{"date-parts":[[2007,11,14]],"date-time":"2007-11-14T17:04:10Z","timestamp":1195059850000},"page":"791-797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Hexamethylene bisacetamide inhibits malignant phenotype in T-ALL cell lines"],"prefix":"10.1016","volume":"32","author":[{"given":"V.","family":"Cecchinato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Erba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Basile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Scarpati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Fazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Brando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Comi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Chiaramonte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2007.09.008_bib1","doi-asserted-by":"crossref","first-page":"10251","DOI":"10.1073\/pnas.91.22.10251","article-title":"Inducing differentiation of transformed cells with hybrid polar compounds: a cell cycle-dependent process","volume":"91","author":"Marks","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2007.09.008_bib2","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1182\/blood.V80.10.2604.2604","article-title":"Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation-inducing agent","volume":"80","author":"Andreeff","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.09.008_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0764-4469(99)80039-0","article-title":"Hybrid polar inducers of transformed cell differentiation\/apoptosis. From the cell to the clinic","volume":"322","author":"Marks","year":"1999","journal-title":"CR Acad Sci III"},{"key":"10.1016\/j.leukres.2007.09.008_bib4","first-page":"165","article-title":"Modulation of the c-myb, c-myc and p53 mRNA and protein levels during induced murine erythroleukemia cell differentiation","volume":"4","author":"Richon","year":"1989","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2007.09.008_bib5","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1073\/pnas.95.1.162","article-title":"Hexamethylene bisacetamide induces programmed cell death (apoptosis) and down-regulates Bcl-2 expression in human myeloma cells","volume":"95","author":"Siegel","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2007.09.008_bib6","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/(SICI)1097-4644(19990501)73:2<164::AID-JCB3>3.0.CO;2-0","article-title":"Notch-1 inhibits apoptosis in murine erythroleukemia cells and is necessary for differentiation induced by hybrid polar compounds","volume":"73","author":"Shelly","year":"1999","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.leukres.2007.09.008_bib7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0092-8674(91)90111-B","article-title":"TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms","volume":"66","author":"Ellisen","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2007.09.008_bib8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.leukres.2007.09.008_bib9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/jcb.10383","article-title":"Differential regulation of Notch signal transduction in leukemia and lymphoma cells in culture","volume":"88","author":"Chiaramonte","year":"2003","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.leukres.2007.09.008_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.canlet.2004.07.022","article-title":"A wide role for NOTCH1 signaling in acute leukemia","volume":"219","author":"Chiaramonte","year":"2005","journal-title":"Cancer Lett"},{"key":"10.1016\/j.leukres.2007.09.008_bib11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S1074-7613(00)80643-3","article-title":"Correlating Notch signaling with thymocyte maturation","volume":"9","author":"Deftos","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.leukres.2007.09.008_bib12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by acid guanidinium\u2013thiocyanate\u2013phenol\u2013chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal Biochem"},{"key":"10.1016\/j.leukres.2007.09.008_bib13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0959-8049(00)00357-9","article-title":"Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action","volume":"37","author":"Erba","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.leukres.2007.09.008_bib14","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1128\/MCB.01091-06","article-title":"Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc","volume":"26","author":"Sharma","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.leukres.2007.09.008_bib15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0092-8674(00)80416-X","article-title":"DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2","volume":"91","author":"Shieh","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2007.09.008_bib16","first-page":"835","article-title":"Changes in DNA associated with induction of erythroid differentiation by dimethyl sulfoxide in murine erythroleukemia cells","volume":"38","author":"Terada","year":"1978","journal-title":"Cancer Res"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212607003499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212607003499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:56:10Z","timestamp":1758934570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212607003499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0145212607003499"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2007.09.008","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hexamethylene bisacetamide inhibits malignant phenotype in T-ALL cell lines","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2007.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}